Google Store

WSPN Empowers Digital Payment Ecosystem with Key Milestones

Retrieved on: 
Tuesday, January 23, 2024

WSPN remains dedicated to fostering accessibility and liquidity in the digital payment ecosystem, and the BitMart listing is a significant step towards achieving this goal.

Key Points: 
  • WSPN remains dedicated to fostering accessibility and liquidity in the digital payment ecosystem, and the BitMart listing is a significant step towards achieving this goal.
  • WSPN also introduces the official digital wallet, StableWallet, now available for download on both Apple Store and Google Store.
  • By joining forces with established players in the industry, WSPN aims to set new standards for transparency, security, and innovation in the digital payment space.
  • "We are thrilled to announce these major milestones in our journey towards shaping the future of digital payment," said Raymond Yuan, Founder and CEO at WSPN.

REPX has Presented Its Strategic Report and Financials for Year 2022 and Half-Yearly Report 2023

Retrieved on: 
Friday, October 27, 2023

London, England--(Newsfile Corp. - October 27, 2023) - The Reputation Exchange (REPX) has presented its strategic report, report of the directors and financial statements for the year ended 31 December 2022 and its half-yearly report 2023.

Key Points: 
  • London, England--(Newsfile Corp. - October 27, 2023) - The Reputation Exchange (REPX) has presented its strategic report, report of the directors and financial statements for the year ended 31 December 2022 and its half-yearly report 2023.
  • The past year, 2022, was a very difficult year for REPX and all the fintech sector.
  • This caused a knock-on effect on REPX: the listing on LSE was postponed to a future date and to a better overall market condition.
  • The Company published in the terms required by the Cyprus Stock Exchange both its audited financials for 2022 and its half-yearly report for 2023.

GPCR Therapeutics Announces Publication on Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100

Retrieved on: 
Thursday, October 26, 2023

These findings strongly support the use of this combination for peripheral blood HSC harvest in autologous stem cell transplant treatment in hematological cancers.

Key Points: 
  • These findings strongly support the use of this combination for peripheral blood HSC harvest in autologous stem cell transplant treatment in hematological cancers.
  • The paper, authored in collaboration with Seoul National University’s School of Biological Sciences and Institute of Microbiology, is entitled, “GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol” (1).
  • The authors highlight that GPC-100 alone shows greater mobilization efficacy than a drug already approved for stem cell mobilization.
  • Increasingly, clinicians are using Autologous Stem Cell Transplant (ASCT) to treat patients, which has improved the anti-cancer response and survival compared to conventional chemotherapy.

July 2023’s Most Wanted Malware: Remote Access Trojan (RAT) Remcos Climbs to Third Place while Mobile Malware Anubis Returns to Top Spot

Retrieved on: 
Wednesday, August 9, 2023

Researchers found that Remcos moved to third place after threat actors created fake websites last month to spread malicious downloaders carrying the RAT.

Key Points: 
  • Researchers found that Remcos moved to third place after threat actors created fake websites last month to spread malicious downloaders carrying the RAT.
  • Meanwhile, mobile banking Trojan Anubis knocked relative newcomer SpinOk from top spot on the mobile malware list, and Education/Research was the most impacted industry.
  • Remcos is a RAT first seen in the wild in 2016 and is regularly distributed through malicious Microsoft documents or downloaders.
  • Last month Anubis took first place in the most prevalent Mobile malware, followed by SpinOk and AhMyth.

Fresenius Kabi Launches Plerixafor Injection

Retrieved on: 
Wednesday, August 9, 2023

Fresenius Kabi announced today it has introduced Plerixafor Injection, a generic equivalent to Mozobil®, available immediately in the United States in a 24 mg per 1.2 mL single dose vial.

Key Points: 
  • Fresenius Kabi announced today it has introduced Plerixafor Injection, a generic equivalent to Mozobil®, available immediately in the United States in a 24 mg per 1.2 mL single dose vial.
  • “Fresenius Kabi is pleased to add Plerixafor Injection to our oncology portfolio, further demonstrating our commitment to expanding access to high-quality and cost-effective oncology medicines in the United States,” said John Ducker, president and CEO of Fresenius Kabi USA.
  • Plerixafor is contraindicated in patients with a history of hypersensitivity to Plerixafor.
  • This Important Safety Information does not include all the information needed to use Plerixafor Injection safely and effectively.

Onyxia Cyber Unveils AI-Powered Cybersecurity Performance Management Platform, Enabling Proactive Risk Management

Retrieved on: 
Thursday, August 3, 2023

NEW YORK, Aug. 3, 2023 /PRNewswire/ -- Onyxia Cyber ("Onyxia") today unveiled the first AI-powered Cybersecurity Performance Management (CPM) platform, a vital management platform for security leaders to better measure the performance of their cybersecurity programs and reduce risk. By having real-time Cybersecurity Performance Indicator (CPI) metrics and actionable security program recommendations, security leaders can build and customize their cybersecurity program assessments, optimize their programs' return on investments, and automate board-level reporting.

Key Points: 
  • NEW YORK, Aug. 3, 2023 /PRNewswire/ -- Onyxia Cyber ("Onyxia") today unveiled the first AI-powered Cybersecurity Performance Management (CPM) platform, a vital management platform for security leaders to better measure the performance of their cybersecurity programs and reduce risk.
  • With Onyxia, CISOs have a single place to measure, manage and convey the business value of their cybersecurity programs.
  • "Onyxia is changing that paradigm and transforming a reactive industry into proactive protection with our comprehensive CPM platform.
  • Cutting-Edge AI Integration: Leveraging AI technology, Onyxia's CPM platform ensures a more precise and comprehensive assessment of cybersecurity performance.

Chobani Names Top Brand Talent Thomas Ranese New Chief Marketing Officer

Retrieved on: 
Tuesday, August 1, 2023

NEW BERLIN, N.Y., Aug. 1, 2023 /PRNewswire/ -- Chobani, a next generation food and beverage company originally known for its Greek yogurt, has named Thomas Ranese as its new Chief Marketing Officer.

Key Points: 
  • NEW BERLIN, N.Y., Aug. 1, 2023 /PRNewswire/ -- Chobani, a next generation food and beverage company originally known for its Greek yogurt, has named Thomas Ranese as its new Chief Marketing Officer.
  • Ranese joins the Chobani executive leadership team from Abbott having previously served in marketing leadership roles at Uber and Google.
  • "The name 'Chobani' stands for something better – better ingredients, better quality, better nutrition and a better way of doing business.
  • Kevin Burns, Chobani President and Chief Operations Officer, added: "Thomas brings a unique combination of creativity and business acumen with deep expertise in brand building, digital strategy and integrated marketing that will be critical as we continue to innovate, scale our brand and drive growth in new categories.

May 2023’s Most Wanted Malware: New Version of Guloader Delivers Encrypted Cloud-Based Payloads

Retrieved on: 
Friday, June 9, 2023

Researchers reported on a new version of shellcode-based downloader GuLoader, which was the fourth most prevalent malware last month.

Key Points: 
  • Researchers reported on a new version of shellcode-based downloader GuLoader, which was the fourth most prevalent malware last month.
  • With fully encrypted payloads and anti-analysis techniques, the latest form can be stored undetected in well-known public cloud services, including Google Drive.
  • The payloads are fully encrypted and stored undetected in renowned public cloud services, including Google Drive.
  • It has recently been seen abusing a dynamic link library (DLL) hijacking flaw in the Windows 10 WordPad program to infect computers.

April 2023’s Most Wanted Malware: Qbot Launches Substantial Malspam Campaign and Mirai Makes its Return

Retrieved on: 
Thursday, May 11, 2023

Last month, researchers uncovered a substantial Qbot malspam campaign distributed through malicious PDF files attached to emails seen in multiple languages.

Key Points: 
  • Last month, researchers uncovered a substantial Qbot malspam campaign distributed through malicious PDF files attached to emails seen in multiple languages.
  • Researchers found instances of the malspam being sent in multiple different languages, which means organizations can be targeted worldwide.
  • Last month also saw the return of Mirai, one of the most popular IoT malwares.
  • This latest campaign follows an extensive report published by Check Point Research (CPR) on the prevalence of IOT attacks .

Speck Announces Innovative New Line of 'Made for Google' Accessories for Pixel Tablet and Pixel Fold

Retrieved on: 
Wednesday, May 10, 2023

SAN MATEO, Calif. , May 10, 2023 /PRNewswire/ -- Today, Speck announced a new line of innovative products that were designed in partnership with Google for their Pixel Tablet and Pixel Fold.

Key Points: 
  • SAN MATEO, Calif. , May 10, 2023 /PRNewswire/ -- Today, Speck announced a new line of innovative products that were designed in partnership with Google for their Pixel Tablet and Pixel Fold.
  • Speck announces a new line of innovative products designed in partnership with Google for Pixel Tablet and Pixel Fold.
  • Microban® antimicrobial product protection, a soft-touch coating, and one-year warranty make StandyShell the perfect protective partner for the Google Pixel Tablet.
  • Presidio™ Perfect-Clear Fold Case for Google Pixel Fold ($59.95) – Google's Pixel Fold represents a bold leap in technical achievement and usability.